List view / Grid view




Lorenz Mayr joins Drug Discovery 2017 speaker lineup

31 January 2017 | By

Lorenz Mayr, esteemed Vice President and Global Head of Biological Reagents and Assay Development at AstraZeneca will be joining the expert speaker lineup for the launch conference on Drug Discovery. The event takes place on 27 and 28 April 2017 in London.


Takeda to enrol 5000 patients in giant multiple myeloma trial

1 September 2016 | By Niamh Louise Marriott, Digital Content Producer

Takeda’s global non-interventional, observational multiple myeloma study is now enrolling patients, aiming to have 5,000 patients over three years with a goal of following each patient for a minimum of five years in an effort to track patterns in disease presentation, patient characteristics, treatment and outcomes, thereby enhancing the understanding…